These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19205549)

  • 21. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
    Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
    Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis.
    Thiele H; Neumann-Schniedewind P; Jacobs S; Boudriot E; Walther T; Mohr FW; Schuler G; Falk V
    J Am Coll Cardiol; 2009 Jun; 53(25):2324-31. PubMed ID: 19539141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
    Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
    Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy.
    Tham EB; Yeung AC; Cheng CW; Bernstein D; Chin C; Feinstein JA
    J Heart Lung Transplant; 2005 Jun; 24(6):769-73. PubMed ID: 15949739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
    Harjai KJ; Orshaw P; Boura J; Sporn D
    Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
    Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
    Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Left main coronary artery stenosis].
    Sheiban I; Biondi-Zoccai GG; Moretti C
    G Ital Cardiol (Rome); 2008 Oct; 9(10):684-9. PubMed ID: 18942556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-stent restenosis in idiopathic isolated ostial left main coronary artery stenosis.
    Jim MH; Yiu KH; Chow WH
    Int J Cardiol; 2007 Jan; 114(3):e111-3. PubMed ID: 17049638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).
    Kaltoft A; Jensen LO; Maeng M; Tilsted HH; Thayssen P; Bøttcher M; Lassen JF; Krusell LR; Rasmussen K; Hansen KN; Pedersen L; Johnsen SP; Sørensen HT; Thuesen L
    J Am Coll Cardiol; 2009 Feb; 53(8):658-64. PubMed ID: 19232897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery.
    Taggart DP; Kaul S; Boden WE; Ferguson TB; Guyton RA; Mack MJ; Sergeant PT; Shemin RJ; Smith PK; Yusuf S
    J Am Coll Cardiol; 2008 Mar; 51(9):885-92. PubMed ID: 18308155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of left main coronary artery stenosis with drug-eluting stent following heart transplantation.
    Xue YZ; Liu WT; Wang XH; Gao H; Wang LX
    Intern Med; 2012; 51(9):1037-41. PubMed ID: 22576383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left main drug-eluting stents: natural progression or a bridge too far?
    Stone GW; Moses JW; Leon MB
    J Am Coll Cardiol; 2007 Aug; 50(6):498-500. PubMed ID: 17678731
    [No Abstract]   [Full Text] [Related]  

  • 33. Value of drug-eluting stents in cardiac transplant recipients.
    Gupta A; Mancini D; Kirtane AJ; Kaple RK; Apfelbaum MA; Kodali SK; Marboe C; Leon MB; Moses JW; Rabbani LE
    Am J Cardiol; 2009 Mar; 103(5):659-62. PubMed ID: 19231329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
    Silber S; Colombo A; Banning AP; Hauptmann K; Drzewiecki J; Grube E; Dudek D; Baim DS
    Circulation; 2009 Oct; 120(15):1498-504. PubMed ID: 19786634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of multiple drug-eluting stents in the treatment of cardiac transplant vasculopathy.
    Garg R; Singh A; Aggarwal K
    South Med J; 2008 Dec; 101(12):1252-4. PubMed ID: 19005455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents.
    Granillo GA; van Dijk LC; McFadden EP; Serruys PW
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):23-7. PubMed ID: 15619320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
    Onuma Y; Kukreja N; Piazza N; Eindhoven J; Girasis C; Schenkeveld L; van Domburg R; Serruys PW;
    J Am Coll Cardiol; 2009 Jul; 54(3):269-76. PubMed ID: 19589442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study.
    Bhargava B; Karthikeyan G; Shankar PB; Seth S; Singh S; Pr U; Lal AV; Mohanty M
    Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.